innerbanner

Publications

Search
TitleArsenic-induced mice model of Parkinson’s disease: Revealing the neurotoxicity of arsenic through mitochondrial complexes inhibition and dopaminergic neurodegeneration in the substantia nigra region of brain
Faculty Authors Dr. Pallab BhattacharyaImpact Factor2.7Year 2025
DOI Numberdoi.org/10.1016/j.brainres.2025.149493Page No149493Volume No1851
Department Department of PharmaceuticsPaper TypeResearchIssue No
Journal NameBrain Research
TitleROS-responsive nucleobase conjugated chitosan: Synthesis and evaluations for biomedical applications
Faculty Authors Dr. Bichismita Sahu, Dr. Sapan BorahImpact Factor10.7Year 2025
DOI Numberdoi.org/10.1016/j.carbpol.2025.123353Page No123353Volume No356
Department Department of Medicinal ChemistryPaper TypeResearchIssue No
Journal NameCarbohydrate Polymers
TitleGlycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson’s Disease
Faculty Authors Dr. Ravi ShahImpact Factor3.5Year 2025
DOI Numberdoi.org/10.1021/acschembio.4c00777Page NoVolume No
Department Department of Pharmaceutical AnalysisPaper TypeResearchIssue No
Journal NameACS Chemical Biology
TitleChapter 3 Topographic Properties of PEGylated Nanocarriers
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_3Page Nopp 69–105Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 2 Methods and Protocols for the Synthesis of PEGylated Pharmaceutical Nanocarriers
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_2Page Nopp 29–67Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 6 PEGylation as a Tool to Alter Immunological Properties of Nanocarriers
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_6Page Nopp 171–193Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 5 PEGylated Nanocarriers for Solubilization
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_5Page Nopp 137–169Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 7 PEGylated Nanocarrier as a Promising Tool for Site-Specific Delivery of Therapeutics
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_7Page Nopp 195–238Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 10 PEGylated Nanocarriers for Protein and Peptide Delivery
Faculty AuthorsImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_10Page Nopp 295–316Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
TitleChapter 11 PEGylation of Therapeutic Proteins and Peptides
Faculty Authors Dr. Rakesh Kumar TekadeImpact FactorYear 2025
DOI Numberhttps://doi.org/10.1007/978-981-97-7316-9_11Page Nopp 317–343Volume No
Department Department of PharmaceuticsPaper TypeBook Chapter PaperIssue No
Journal NamePEGylated Nanocarriers in Medicine and Pharmacy
Back to top Back to top